MedPath
HSA Approval

DEXACAP TABLET 12.5 mg

SIN08473P

DEXACAP TABLET 12.5 mg

DEXACAP TABLET 12.5 mg

December 13, 1995

APOTHECA MARKETING PTE LTD

APOTHECA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPOTHECA MARKETING PTE LTD
Licence HolderAPOTHECA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA01

captopril

Manufacturer Information

APOTHECA MARKETING PTE LTD

PT DEXA MEDICA

Active Ingredients

CAPTOPRIL

12.5 mg

Captopril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXACAP TABLET 12.5 mg - HSA Approval | MedPath